REFERENCES
- Nguyen, V.T.; Law, M.G.; Dore, G.J. An enormous hepatitis B virus-related liver disease burden projected in Vietnam by 2025. Liver Int 2008, 28(4), 525–531.
- Feitelson, M.A.; Lee, J. Hepatitis B virus integration, fragile sites, and hepatocarcinogenesis. Cancer Lett 2007, 252(2), 157–170.
- Lupberger, J.; Hildt, E. Hepatitis B virus-induced oncogenesis. World J Gastro 2007, 13(1), 74–81.
- Huang, Y.; Wang, Z.; An, S.; Zhou, B.; Zhou, Y.; Chan, H.L.; Hou, J. Role of hepatitis B virus genotypes and quantitative HBV DNA in metastasis and recurrence of hepatocellular carcinoma. J Med Virol 2008, 80(4), 591–597.
- O'Grady, A.; Dunne, C.; O'Kelly, P.; Murphy, G.M.; Leader, M.; Kay, E. Differential expression of matrix metalloproteinase (MMP)-2, MMP-9 and tissue inhibitor of metalloproteinase (TIMP)-1 and TIMP-2 in non-melanoma skin cancer: implications for tumour progression. Histopathology 2007, 51(6), 793–804.
- Tong, W.P.; Zhou, Y.; Wang, X.; Yang, F.; Wu, K.L; Wu, J.; Zhang, Y. An accurate quantitative method for screening effective siRNA probes targeting a hepatitis B virus transcript in single living cells. Biochem Biophys Res Commun 2008, 367(4), 866–873.
- Liang, X.; Qu, Z.; Zhang, Z.; Du, J.; Liu, Y.; Cui, M.; Liu, H.; Gao, L.; Han, L.; Liu, S.; Cao, L.; Zhao, P.; Sun, W. Blockade of preS2 down-regulates the apoptosis of HepG2.2.15 cells induced by TRAIL. Biochem Biophys Res Commun 2008, 369(2), 456–463.
- Wang, Y.; Xu, H.T.; Ueda, Y.; Shimasaki, M.; Wang, E.H. Activation ratio of MMP-2 and expression of MT1-MMP are correlated in thymic epithelial tumours. Pathology 2007, 39(5), 486–490.
- Khosravi, S.P.; Fernandez, P.I. Tumoral angiogenesis: review of the literature. Cancer Invest 2008, 26(1), 104–108.
- Ou, D.P.; Tao, Y.M.; Tang, F.Q.; Yang, L.Y. The hepatitis B virus X protein promotes hepatocellular carcinoma metastasis by upregulation of matrix metalloproteinases. Int J Cancer 2007, 120(6), 1208–1214.
- Moon, E.J.; Jeong, C.H.; Jeong, J.W.; Kim, K.R.; Yu, D.Y.; Murakami, S.; Kim, C. W.; Kim, K.W. Hepatitis B virus X protein induces angiogenesis by stabilizing hypoxia-inducible factor-1alpha. Faseb J 2004, 18(2), 382–384.
- Maeda, S.; Omata, M. Inflammation and cancer: role of nuclear factor-kappaB activation. Cancer Sci 2008, 99(5), 836–842.
- Rayet, B.; Gelinas, C. Aberrant rel/nfkb genes and activity in human cancer. Oncogene 1999, 18(49), 6938–6947.
- Palayoor, S.T.; Youmell, M.Y.; Calderwood, S.K.; Coleman, C.N.; Price, B.D. Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene 1999, 18(51), 7389–7394.
- Arsura, M.; Cavin, L.G. Nuclear factor-kappaB and liver carcinogenesis. Cancer Lett 2005, 229(2), 157–169.
- Park, S.G.; Chung, C.; Kang, H.; Kim, J.Y.; Jung, G. Up-regulation of cyclin D1 by HBx is mediated by NF-kappaB2/BCL3 complex through kappaB site of cyclin D1 promoter. J Biol Chem 2006, 281(42), 31770–31777.
- Pearson, A.L.; Colville, N.P.; Kwan, J.T. Dockrell ME.Albumin induces interleukin-6 release from primary human proximal tubule epithelial cells. J Nephrol 2008, 21(6), 887–893.
- Yang, L.L.; Liang, Y.C.; Chang, C.W.; Lee, W.S.; Kuo, C.T.; Wang, C.C.; Lee, H.M.; Lin, C.H. Effects of sphondin, isolated from Heracleum laciniatum, on IL-1beta-induced cyclooxygenase-2 expression in human pulmonary epithelial cells. Life Sci 2002, 72(2), 199–213.
- Nai, Y.J.; Jiang, Z.W.; Wang, Z.M.; Li, N.; Li, J.S. Prevention of cancer cachexia by pyrrolidine dithiocarbamate (PDTC) in colon 26 tumor-bearing mice. JPEN J Parenter Enteral Nutr 2007, 31(1), 18–25.
- Rangan, G.K.; Wang, Y.; Tay, Y.C.; Harris, D.C. Cytokine gene expression in Adriamycin nephropathy: effects of antioxidant nuclear factor kappaB inhibitors in established disease. Nephron 2000, 86(4), 482–490.
- Nör, J.; Christensen, J.; Liu, J.; Peters, M.; Mooney, D.; Strieter, R. Up-regulation of Bcl-2 in microvascular endothelial cells enhances intratumoral angiogenesis and accelerates tumor growth. Cancer Res 2001, 61(5), 2183–2188.
- Poon, R.; Ng, I.; Lau, C.; Yu, W.; Yang, Z.; Fan, S. Tumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: a prospective study. J Clin Oncol 2002, 20(7), 1775–1785.
- Qiao, L.; Zhang, H.; Yu, J.; Francisco, R.; Dent, P.; Ebert, M.P.; Rocken, C.; Farrell, G. Constitutive activation of NF-kappaB in human hepatocellular carcinoma: evidence of a cytoprotective role. Hum Gene Ther 2006, 17(3), 280–290.
- Tai, D.I.; Tsai, S.L.; Chang, Y.H.; Huang, S.N.; Chen, T.C.; Chang, K.S.; Liaw, Y.F. Constitutive activation of nuclear factor kappaB in hepatocellular carcinoma. Cancer 2000, 89(11), 2274–2281.
- Yun, C.; Um, H.R.; Jin, Y.H.; Wang, J.H.; Lee, M.O.; Park, S.; Lee, J.H.; Cho, H. NF-kappaB activation by hepatitis B virus X (HBx) protein shifts the cellular fate toward survival. Cancer Lett 2002, 184(1), 97–104.
- Nurmi, A.; Vartiainen, N.; Pihlaja, R.; Goldsteins, G.; Yrjanheikki, J.; Koistinaho, J. Pyrrolidine dithiocarbamate inhibits translocation of nuclear factor kappa-B in neurons and protects against brain ischaemia with a wide therapeutic time window. J Neurochem 2004, 91(3), 755–765.
- Yoo, Y.G.; Oh, S.H.; Park, E.S.; Cho, H.; Lee, N.; Park, H.; Kim, D.K.; Yu, D.Y.; Seong, J.K.; Lee, M.O. Hepatitis B virus X protein enhances transcriptional activity of hypoxia-inducible factor-1alpha through activation of mitogen-activated protein kinase pathway. J Biol Chem 2003, 278(40), 39076–39084.
- Scortegagna, M.; Cataisson, C.; Martin, R.J.; Hicklin, D.J.; Schreiber, R.D.; Yuspa, S.H.; Arbeit, J.M. HIF-1alpha regulates epithelial inflammation by cell autonomous NF kappa B activation and paracrine stromal remodeling. Blood 2008, 111(7), 3343–3354.
- Golubkov, V.S.; Chekanov, A.V.; Shiryaev, S.A.; Aleshin, A.E.; Ratnikov, B.I.; Gawlik, K.; Radichev, I.; Motamedchaboki, K.; Smith, J.W.; Strongin, A.Y. Proteolysis of the membrane type-1 matrix metalloproteinase prodomain: implications for a two-step proteolytic processing and activation. J Biol Chem 2007, 282(50), 36283–36291.
- Takahra, T.; Smart, D.E.; Oakley, F.; Mann, D.A. Induction of myofibroblast MMP-9 transcription in three-dimensional collagen I gel cultures: regulation by NF-kappaB, AP-1 and Sp1. Int J Biochem Cell Biol 2004, 36(2), 353–363.
- Martín, V.; Sanz, C.; Rodríguez, M.; Majano, P.; Molina, J.; López, C. The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells. Hepatology 2008, 47(6), 1872–1883.
- Sato, H.; Takino, T.; Okada, Y.; Cao, J.; Shinagawa, A.; Yamamoto, E.; Seiki, M. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994, 370(6484), 61–65.
- Pang, R.; Poon, R. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006, 242(2), 151–167.
- Mira, E.; Lacalle, R.; Buesa, J.; Buitrago, G.; Jiménez, B.; Gómez, M. Secreted MMP9 promotes angiogenesis more efficiently than constitutive active MMP9 bound to the tumor cell surface. J Cell Sci 2004, 117(9), 1847–1857.
- Basile, J.; Holmbeck, K.; Bugge, T.; Gutkind, J. MT1-MMP controls tumor-induced angiogenesis through the release of semaphorin 4D. J Biol Chem 2007, 282(9), 6899–6905.
- Chikazawa, M.; Inoue, K.; Fukata, S.; Karashima, T.; Shuin, T. Expression of angiogenesis-related genes regulates different steps in the process of tumor growth and metastasis in human urothelial cell carcinoma of the urinary bladder. Pathobiology 2008, 75(6), 335–345.